PET-Based Dual-Modal Probes for In Vivo Imaging

Area of Science:

• Biomedical Imaging
• Molecular Imaging
• Radiochemistry

Background:

• Single-modal imaging techniques have limitations in analyzing in vivo metabolic processes.
• Dual-modal imaging, especially positron emission tomography (PET)-based combinations, offers enhanced capabilities.
• Integration with magnetic resonance imaging (MRI) or near-infrared fluorescence (NIRF) imaging is a key advancement.

Purpose of the Study:

• To review recent progress in PET-based dual-modal imaging.
• To highlight the development of various bimodal probes (antibodies, nanoparticles, peptides).
• To discuss key applications such as image-guided surgery and disease assessment.

Main Methods:

• Review of recent scientific literature on PET-based dual-modal imaging.
• Focus on the design and application of bimodal probes.
• Analysis of advancements in probe development and clinical utility.

Main Results:

• PET-based dual-modal imaging significantly improves resolution and provides functional insights.
• Bimodal probes derived from antibodies, nanoparticles, and peptides show promise.
• Applications in image-guided surgery and disease assessment are expanding.

Conclusions:

• PET-based dual-modal imaging offers a comprehensive view of disease processes for accurate diagnosis and targeted treatment.
• Future research should focus on optimizing probe design for biocompatibility, safety, and clinical translation.
• Interdisciplinary collaboration is crucial for broadening applications and improving patient outcomes.